Evidence Hub

Discovery and mechanistic elucidation of 2,4-resorcinol-based potent human tyrosinase inhibitors through integrated experimental and computational approaches

Hwang IY, Sharma R, Mai DHA, Ngo A, Do SG, Jia Q, Lee EY

International journal of biological macromolecules, 2026

Abstract

Tyrosinase is a copper-dependent enzyme essential for melanin biosynthesis and a validated target for managing hyperpigmentation. To discover potent inhibitors, we synthesized and screened 120 resorcinol-based analogues using mushroom tyrosinase (abTYR) assays and B16 melanoma cell models. This experimental workflow identified five promising candidates for further evaluation. Compound 3 consistently emerged as the lead inhibitor, demonstrating submicromolar potency against abTYR (IC50 = 0.2 μM), strong cellular efficacy in suppressing melanogenesis (IC50 = 1.6 μM) in B16 cells, and the broadest safety margin (LD50 = 345.9 μM; TI ≈ 216). To elucidate its mechanism, a homology model of human tyrosinase (hsTYR) was constructed and analyzed through molecular docking, molecular dynamics simulations, and MM-PBSA free energy calculations, which confirmed stable interactions with the conserved binuclear copper center. These results highlight the value of combining experiment-driven prioritization with structure-guided modeling and identify compound 3 as a promising and selective inhibitor of hsTYR for therapeutic and cosmetic applications.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free